Healthcare IT News: The National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, has launched a clinical trial of a vaccine intended to prevent Zika virus infection. The NIH is evaluating the experimental vaccine’s safety and its ability to generate an immune system response among clinical trial participants.
The number of confirmed Zika cases as of press time reached 15 in Miami and no vaccines or specific therapeutics to prevent or treat the virus currently exist.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now